LEADER 01472nam  2200409   450 
001 9910716785603321
005 20210805095931.0
035   $a(CKB)5470000002524316
035   $a(OCoLC)1262871639
035   $a(EXLCZ)995470000002524316
100   $a20210805d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiodefense: after-action findings and COVID-19 response revealed opportunities to strengthen preparedness $ereport to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2021.
215   $a1 online resource (iii, 77 pages) $ccolor illustrations
300   $a"August 2021."
300   $a"GAO-21-513."
320   $aIncludes bibliographical references.
517   $aBiodefense
606   $aBiosecurity$zUnited States
606   $aCommunicable diseases$zUnited States$xPrevention
606   $aInteragency coordination$zUnited States
606   $aCOVID-19 (Disease)$zUnited States
615  0$aBiosecurity
615  0$aCommunicable diseases$xPrevention.
615  0$aInteragency coordination
615  0$aCOVID-19 (Disease)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910716785603321
996   $aBiodefense: after-action findings and COVID-19 response revealed opportunities to strengthen preparedness$93537325
997   $aUNINA